Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Breast cancer 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬Breast cancer
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
||||||||||||||||||||||||||||||||
| 2 | Chemical carcinogenesis - receptor activation 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬Chemical carcinogenesis - receptor activation
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
||||||||||||||||||||||||||||||||
| 3 | Cytokine-cytokine receptor interaction 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬Cytokine-cytokine receptor interaction
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
||||||||||||||||||||||||||||||||
| 4 | NF-kappa B signaling pathway 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬NF-kappa B signaling pathway
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
||||||||||||||||||||||||||||||||
| 5 | Osteoclast differentiation 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬Osteoclast differentiation
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
||||||||||||||||||||||||||||||||
| 6 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬Parathyroid hormone synthesis, secretion and action
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
||||||||||||||||||||||||||||||||
| 7 | Prolactin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬Prolactin signaling pathway
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
||||||||||||||||||||||||||||||||
| 8 | Rheumatoid arthritis 💬 1 gene, 1 drug (DrugBank) and 11 diseases |
TNFSF11 [1] TNFSF11 💬Breast cancer
|
Denosumab Denosumab 💬Rheumatoid arthritis
| Denosumab | 046 [11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬1. Breast cancer
|
Breast cancer
1 gene, 1 drug (DrugBank) and 11 diseases
Chemical carcinogenesis - receptor activation
1 gene, 1 drug (DrugBank) and 11 diseases
Cytokine-cytokine receptor interaction
1 gene, 1 drug (DrugBank) and 11 diseases
NF-kappa B signaling pathway
1 gene, 1 drug (DrugBank) and 11 diseases
Osteoclast differentiation
1 gene, 1 drug (DrugBank) and 11 diseases
Parathyroid hormone synthesis, secretion and action
1 gene, 1 drug (DrugBank) and 11 diseases
Prolactin signaling pathway
1 gene, 1 drug (DrugBank) and 11 diseases
Rheumatoid arthritis
1 gene, 1 drug (DrugBank) and 11 diseases
